Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Diabetes Reviews is Scopus-indexed (Q2, CiteScore 5.4), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1573-3998Verify ISSN ↗1875-6417Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 96 / 250 | 61st | Q2 |
| Endocrinology | 62 / 132 | 53rd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–present (also 1996), best quartile Q2, CiteScore 5.4.
Current Diabetes Reviews is Q2 in Endocrinology, Diabetes and Metabolism (rank 96 of 250) and Q2 in Endocrinology (rank 62 of 132), by CiteScore 2025.
Current Diabetes Reviews is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.4, which places it in quartile Q2 at the 61st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.660, quartile Q3, with an H-index of 77.
Current Diabetes Reviews is published by Bentham Science Publishers. Its print ISSN is 1573-3998 and its online ISSN is 1875-6417.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Diabetes Reviews has an h-index of 86 and a 2-year mean of 3.17 citations per paper (OpenAlex). Its Scopus CiteScore is 5.4, quartile Q2. On 2-year citations it ranks #76 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Current Diabetes Reviews published 40 papers in 2025; its busiest recent year was 2020 with 125. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from India (28.1%), China (16.4%) and Iran (6.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.